Detailed Information on Publication Record
2014
Neutralizing antibodies can initiate genome release from human enterovirus 71
PLEVKA, Pavel, P.Y. LIM, R. PERERA, J. CARDOSA, A. SUKSATU et. al.Basic information
Original name
Neutralizing antibodies can initiate genome release from human enterovirus 71
Authors
PLEVKA, Pavel (203 Czech Republic, guarantor, belonging to the institution), P.Y. LIM (458 Malaysia), R. PERERA (840 United States of America), J. CARDOSA (458 Malaysia), A. SUKSATU (840 United States of America), R.J. KUHN (840 United States of America) and M.G. ROSSMANN (840 United States of America)
Edition
Proceedings of the National Academy of Sciences of the United States of America, WASHINGTON, NATL ACAD SCIENCES, 2014, 0027-8424
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10600 1.6 Biological sciences
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 9.674
RIV identification code
RIV/00216224:14740/14:00079179
Organization unit
Central European Institute of Technology
UT WoS
000330999600029
Keywords in English
DECAY-ACCELERATING FACTOR; CELL ENTRY; CRYSTAL-STRUCTURE; POLIOVIRUS; RECEPTOR; INTERMEDIATE; PICORNAVIRUS; PARTICLE; VIRUS; TRANSITIONS
Tags
Tags
International impact, Reviewed
Změněno: 23/2/2015 12:44, Martina Prášilová
Abstract
V originále
Antibodies were prepared by immunizing mice with empty, immature particles of human enterovirus 71 (EV71), a picornavirus that causes severe neurological disease in young children. The capsid structure of these empty particles is different from that of the mature virus and is similar to "A" particles encountered when picornaviruses recognize a potential host cell before genome release. The monoclonal antibody E18, generated by this immunization, induced a conformational change when incubated at temperatures between 4 degrees C and 37 degrees C with mature virus, transforming infectious virions into A particles. The resultant loss of genome that was observed by cryo-EM and a fluorescent SYBR Green dye assay inactivated the virus, establishing the mechanism by which the virus is inactivated and demonstrating that the E18 antibody has potential as an anti-EV71 therapy. The antibody-mediated virus neutralization by the induction of genome release has not been previously demonstrated. Furthermore, the present results indicate that antibodies with genome-release activity could also be produced for other picornaviruses by immunization with immature particles.